Open AccessAdherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins
Author(s) -
Amir Shroufi,
John Powles
Publication year - 2010
Publication title -
journal of epidemiology and community health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.692
H-Index - 170
eISSN - 1470-2738
pISSN - 0143-005X
DOI - 10.1136/jech.2009.091033
Subject(s) - medicine , disease , polypill , intensive care medicine , hydroxymethylglutaryl coa reductase inhibitors , statin
In everyday practice, adherence to preventive medication for cardiovascular disease (CVD) is lower than in clinical trials and appears to decline to approximately 50% by about 5 years. The UK body for the evaluation of health technologies, NICE, currently recommends that persons with a >20% 10-year risk of incident cardiovascular disease receive statins.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom